Atlas Trials

A Study to Assess the Safety and Effectiveness of Pridopidine Compared to Placebo in the Treatment of Levodopa-Induced Dyskinesia in Patients With Parkinson's Disease

Clinical trial NCT03922711 · TERMINATED

Trial details

NCT number
NCT03922711
Sponsor
Prilenia
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Parkinson Disease
Start date
2019-05-22
Primary completion
2020-07-22
Enrollment
23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.